Search results
Earnings Preview: AbbVie (ABBV) Q1 Earnings Expected to Decline
Zacks via Yahoo Finance· 11 hours agoAbbVie (ABBV) doesn't possess the right combination of the two key ingredients for a likely earnings...
The Bad News Heading Into AbbVie's First-Quarter Earnings Report
Investor's Business Daily· 4 hours agoAbbVie stock has slumped 9% off its record high in March and is facing increasingly steep...
AbbVie buyout Cerevel marks trial win for Parkinson’s drug
Seeking Alpha· 2 days agoAbbVie's (ABBV) buyout target, Cerevel Therapeutics (CERE), announced positive data for its...
New York City reports hospitalizations caused by fake Botox. Where is the 'faux-tox' coming from?
NBC Universal via AOL· 2 hours agoThe FDA said that there’s no indication that authentic Botox, from the drugmaker AbbVie, is linked...
Heard on the Street: AbbVie’s Bet on a Neuroscience Drug Maker Just Got Better
The Wall Street Journal· 1 day agoAbbVie’s acquisition of neuroscience biotech Cerevel Therapeutics hasn’t closed yet. Notably, when ...
AbbVie stock gains as Rinvoq succeeds in giant cell arteritis
Seeking Alpha· 1 day agoAbbVie (ABBV) stock gains as the company's JAK inhibitor, upadacitinib, succeeds in a Phase 3 trial...
AbbVie's Upadacitinib shows promise in giant cell arteritis study By Investing.com
Investing.com· 1 day agoThe study met both its primary endpoint and key secondary endpoints, with a higher percentage of...
AbbVie-bound Cerevel reports phase 3 Parkinson's victory in early win for $8.7B deal
FierceBiotech· 1 day agoThe backing singer in AbbVie’s $8.7 billion takeover of Cerevel Therapeutics is having its moment in...
15 Best Monthly Dividend Stocks To Buy Right Now
Insider Monkey via Yahoo Finance· 4 days agoIn this article, we discuss 15 best monthly dividend stocks to buy right now. You can skip our detailed analysis of dividend stocks and their previous...
Is AbbVie a Millionaire Maker?
Motley Fool via Yahoo Finance· 6 days agoBig pharma stocks like AbbVie (NYSE: ABBV) usually aren't high on the list that investors look to for opportunities that could make them into...
